查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1993014

十字韌帶固定裝置市場：依裝置類型、材料、最終用戶和手術類型分類－2026-2032年全球市場預測

Cruciate Ligament Fixation Device Market by Device Type, Material, End User, Procedure Type - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，前十字韌帶 (ACL) 固定裝置市值將達到 16.7 億美元，到 2026 年將成長至 18.9 億美元，到 2032 年將達到 39.2 億美元，複合年成長率為 12.96%。

主要市場統計數據
基準年 2025 16.7億美元
預計年份：2026年 18.9億美元
預測年份：2032年 39.2億美元
複合年成長率 (%) 12.96%

簡要概述影響現代十字韌帶固定裝置在醫療環境中應用的臨床、技術和採購因素的變化。

十字韌帶固定裝置的市場處於外科創新、材料科學和不斷發展的醫療服務模式的交匯點。固定機制和生物材料的創新與韌帶重組技術的改進同步發展。目前，這些技術進步的評估不僅著眼於動態性能，還關注其在不同臨床環境中的易用性以及與早期復健通訊協定的兼容性。

材料創新、手術流程簡化和醫療環境多樣化如何共同重塑固定裝置的產品設計重點和競爭定位？

多項變革正在重塑整個醫療保健系統中十字韌帶固定裝置的研發、評估和應用。聚合物化學和滅菌技術的進步增強了人們對生物可吸收聚合物結構的信心，促使研發人員重新思考裝置設計。這使得裝置在維持初始機械強度的同時，也具備了長期的生物相容性和可預測的吸收特性。同時，金屬合金和表面處理技術的改進，也使得在即時獲得結構剛性的情況下，金屬固定裝置仍效用價值。

到 2025 年，我們將透過製造柔軟性和引人注目的價值提案，克服採購的複雜性和關稅帶來的壓力。

美國關稅政策在2025年發生的累積變化，為十字韌帶固定術領域的製造商、經銷商和醫療採購團隊帶來了新的考量。關稅調整影響了植入組件和專用器械的採購決策，促使各公司重新評估其供應商關係和庫存策略，以維持醫院系統和門診手術中心的成本可預測性。

從細分觀點，我們將闡明設備機制、材料權衡、手術中的移植選擇以及醫療領域的購買行為，從而促進有針對性的商業化。

詳細的細分分析揭示了不同器械類型、材料、最終用戶和手術類型在臨床和商業性趨勢上的顯著差異，為產品策略和分銷管道整合提供了指南。每種器械——皮質紐扣、十字釘、阻斷式骨釘和縫合釘——都具有獨特的操作特性和固定理念。皮質紐扣通常用於懸吊固定，十字釘提供側向穩定性，阻斷式骨釘著重於透過加壓固定移植物，而縫合釘則在需要快速固定的特定臨床場景中發揮作用。了解這些機制上的差異對於使器械訊息與外科醫生的偏好和手術流程相契合至關重要。

來自美洲、歐洲、中東和非洲以及亞太地區的需求，需要採取適應性監管策略和在地化商業性實施方案。

區域趨勢引發了許多監管、臨床和商業方面的考量，這些因素影響著固定裝置的研發、市場推廣和應用。在美洲，臨床上對微創手術的重視以及門診手術的普及，推動了對能夠簡化手術流程並支持早期康復的裝置的需求。該地區的支付方環境和醫院採購結構也是促使裝置展現清晰價值提案和手術效率證據的重要因素。

競爭優勢源自於臨床證據、外科訓練體係以及支持長期應用的強大供應鏈和商業化模式。

十字韌帶固定器材領域的競爭格局呈現出兩極化的特點：既有成熟的醫療設備製造商，也有銳意創新的新興企業，後者注重差異化的器材機制、實證醫學證據以及外科訓練體系。主要企業致力於投資完善的臨床資料收集和外科教育項目，以降低產品推廣門檻；而新興企業則傾向於專注於特定的技術突破，例如新型聚合物配方或簡化器械，從而打入特定的臨床細分市場。

為製造商和供應商提供實用的策略工具，透過簡化設備、強大的採購系統和以證據主導的商業模式來加速部署。

行業領導企業必須使其產品開發和商業策略與臨床醫生的工作流程、監管要求以及不斷變化的採購行為保持一致，以確保永續推廣。應優先考慮能夠降低術中複雜性和減少器械數量的設計，並將這些技術改進與可靠的、經過同行評審的臨床證據以及能夠解決常見推廣障礙的實用培訓模組相結合。在營運方面，應投資開發可客製化的模組化器械系統，使其能夠適應各種移植類型和重組技術，從而擴大其適用範圍，超越外科醫生的個人偏好。

透過結合臨床文獻、相關人員訪談、監管審查和供應鏈分析的嚴格混合方法，可以獲得可操作的商業性見解。

本分析的調查方法整合了臨床文獻回顧、產品性能評估、監管管道分析以及與外科醫生、採購經理和供應鏈經理相關人員的訪談。臨床數據評估旨在提取有關器械性能特徵、手術相容性和長期整合方面的考慮因素，而監管審查則側重於主要司法管轄區的器械分類、核准時間表和上市後監測要求。

在臨床、材料和商業優先事項相互作用的情況下，協調產品、監管和供應鏈策略對於確保永續的臨床部署至關重要。

臨床趨勢、材料科學進步和商業性需求的整合，使得企業亟需將產品創新與實際手術流程和採購實際情況相契合。能夠兼顧外科醫生操作舒適度和可重複固定機制，同時解決生物可吸收聚合物和金屬材料之間權衡取捨的器械，有望在滿足醫院、門診手術中心和專科診所等不同臨床需求方面更具優勢。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 工業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：十字韌帶固定裝置市場：依裝置類型分類

  • 皮革紐帶
  • 十字銷
  • 阻斷式骨釘
  • 主食

第9章：十字韌帶固定裝置市場：依材料分類

  • 生物可吸收聚合物
  • 金屬

第10章：十字韌帶固定裝置市場：依最終用戶分類

  • 門診手術中心
  • 醫院
  • 專科診所

第11章 十字韌帶固定裝置市場：依手術類型分類

  • 前十字韌帶重組手術
    • 同種異體移植
    • 自體膕繩肌腱移植
    • 膝腱自體移植
  • 後十字韌帶重組手術
    • 同種異體移植
    • 自體膕繩肌腱移植
    • 膝腱自體移植

第12章 十字韌帶固定裝置市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章 十字韌帶固定裝置市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 十字韌帶固定裝置市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國十字韌帶固定裝置市場

第16章：中國十字韌帶固定器材市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Arthrex Inc.
  • B. Braun Melsungen AG
  • CONMED Corporation
  • Corin Group
  • Cousin BIoTech
  • DePuy Synthes
  • DJO Global Inc.
  • Exactech Inc.
  • Integra LifeSciences Holdings Corporation
  • Johnson & Johnson Services, Inc.
  • Karl Storz SE & Co. KG
  • LifeNet Health
  • Medacta Group Holding SA
  • Medtronic plc
  • Miach Orthopaedics
  • Olympus Corporation
  • Orthocell Ltd
  • Orthofix Medical Inc.
  • RTI Surgical Holdings, Inc.
  • Smith & Nephew plc
  • Stryker Corporation
  • Tissue Regenix Group plc
  • Wright Medical Group NV
  • Zimmer Biomet Holdings, Inc
  • Ossur hf
Product Code: MRR-1A1A064C01C7

The Cruciate Ligament Fixation Device Market was valued at USD 1.67 billion in 2025 and is projected to grow to USD 1.89 billion in 2026, with a CAGR of 12.96%, reaching USD 3.92 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.67 billion
Estimated Year [2026] USD 1.89 billion
Forecast Year [2032] USD 3.92 billion
CAGR (%) 12.96%

A concise orientation to the evolving clinical, technological, and procurement drivers shaping modern cruciate ligament fixation device adoption across care settings

The cruciate ligament fixation device landscape sits at the intersection of surgical innovation, material science, and evolving care delivery models. Innovations in fixation mechanisms and biomaterials have matured alongside procedural refinements in ligament reconstruction, and these technical advances are now being evaluated not just on biomechanical performance, but on ease of use in diverse clinical settings and compatibility with accelerated rehabilitation protocols.

Clinical stakeholders increasingly weigh factors such as operating-room efficiency, implant removal rates, and long-term tissue integration when selecting fixation solutions. Concurrently, manufacturers are responding with iterative product enhancements that reduce intraoperative steps and offer improved imaging compatibility. As a result, procurement teams and clinical leaders are prioritizing devices that deliver predictable fixation with streamlined instrumentation to lower procedure complexity and enhance surgeon adoption.

Beyond product features, regulatory pathways and reimbursement dynamics are shaping commercialization strategies. Companies must navigate device safety and efficacy evidence requirements while articulating value to hospitals, ambulatory surgical centers, and specialty clinics. This introduction frames the report's emphasis on connecting technological differentiation to end-user needs and outlines the lenses-clinical, operational, and commercial-through which subsequent analysis is presented.

How material innovations, procedural simplification, and care-site diversification are jointly reshaping product design priorities and competitive positioning in fixation devices

Multiple transformative shifts are redefining how cruciate ligament fixation devices are developed, evaluated, and adopted across healthcare systems. Advances in polymer chemistry and sterilization have increased confidence in bioabsorbable polymer constructs, prompting developers to rethink device architectures so that long-term biocompatibility and predictable resorption profiles complement early mechanical strength. Simultaneously, refinements in metal alloys and surface treatments continue to sustain the relevance of metallic fixation options where immediate structural rigidity remains a priority.

Clinical practice patterns are also shifting. Surgeons emphasize minimally disruptive techniques that reduce soft-tissue trauma and shorten operative time, and device designs that simplify graft fixation steps are gaining preference. These procedural demands intersect with the diversification of care venues; ambulatory surgical centers are performing a broader range of ligament reconstructions, which elevates the importance of instrumentation that is compact, facile, and compatible with fast-turnover environments.

Regulatory expectations and payor scrutiny are steering companies toward evidence packages that demonstrate not only safety and biomechanical performance but also practical benefits such as reduced reoperation or simplified inventory. This creates a competitive environment where manufacturers that align product development with real-world clinical workflows and clear value propositions can accelerate clinician uptake. Lastly, supply-chain visibility and manufacturing flexibility have emerged as strategic differentiators, driving investment in dual-sourcing and modular production to mitigate disruption and respond quickly to changing surgeon preferences.

Navigating tariff-induced sourcing complexity and procurement pressure through manufacturing flexibility and compelling value communication in 2025

The cumulative impact of tariff policy changes in the United States during 2025 has introduced new considerations for manufacturers, distributors, and provider procurement teams operating in the cruciate ligament fixation ecosystem. Tariff adjustments influence sourcing decisions for both implant components and specialized instrumentation, encouraging firms to reassess supplier relationships and inventory strategies to preserve cost predictability for hospital systems and ambulatory surgical centers.

Manufacturers with vertically integrated production or regional manufacturing footprints are positioned to respond more nimbly, while companies reliant on cross-border supply chains may need to re-evaluate component sourcing and contractual terms. The tariff environment also amplifies the importance of value messaging; purchasers and clinical leaders will intensify scrutiny of total procedural cost, including implant pricing, operative time, and potential for downstream interventions. Consequently, commercial teams must translate technical differentiators into clear economic narratives that account for tariff-driven cost variances.

Procurement leaders are likely to seek collaborative pricing frameworks and long-term agreements to stabilize supply and cost exposure. For device innovators, demonstrating clinical benefits that offset tariff-induced price pressure-such as reduced revision risk or faster return to function-will be a critical element of commercial positioning. In parallel, strategic partnerships and local assembly initiatives can mitigate tariff effects while supporting market access continuity across diverse provider channels.

Segment-driven clarity on device mechanics, material trade-offs, procedural graft choices, and care-site purchasing behaviors to shape targeted commercialization

A granular view of segmentation reveals distinct clinical and commercial dynamics across device type, material, end user, and procedure type that should guide product strategy and channel engagement. Devices such as cortical buttons, cross pins, interference screws, and staples each present unique handling characteristics and fixation philosophies; cortical buttons often address suspensory fixation needs, cross pins can provide transverse stabilization, interference screws focus on compressive graft fixation, and staples serve roles in select clinical scenarios where rapid anchorage is required. Understanding these mechanistic distinctions is essential when aligning device messaging to surgeon preferences and procedural workflows.

Material choice remains a pivotal axis of differentiation. Bioabsorbable polymer constructs appeal to clinicians prioritizing long-term remodeling and reduced imaging artifacts, while metal implants continue to appeal where immediate mechanical robustness and long-term dimensional stability are paramount. These material considerations intersect with graft choice and reconstruction techniques; anterior cruciate ligament reconstruction and posterior cruciate ligament reconstruction practices vary in graft selection, with both procedure types utilizing allograft options, hamstring tendon autografts, and patellar tendon autografts depending on surgeon training, patient anatomy, and return-to-sport objectives. Device designs and instrumentation must therefore accommodate the biomechanical properties of these graft sources.

End-user setting drives purchasing behavior and utilization patterns. Hospitals maintain the most comprehensive procedural capabilities and stock a broader range of instrumentation and implant types, while ambulatory surgical centers prioritize implants and systems that minimize turnover time and streamline sterilization requirements. Specialty clinics, focused on high-volume or niche procedures, often prioritize surgeon-specific preferences and may favor devices that reduce procedural variability. The overlap between device type, material, procedure, and care site defines distinct buyer personas; tailoring clinical evidence, training, and commercial engagement to these personas increases the likelihood of adoption and sustained use.

Regional imperatives across the Americas, Europe Middle East & Africa, and Asia-Pacific that demand adaptive regulatory strategies and localized commercial execution

Regional dynamics introduce varied regulatory, clinical, and commercial considerations that influence how fixation devices are developed, marketed, and adopted. In the Americas, clinical emphasis on minimally invasive approaches and outpatient procedure expansion drives demand for instrumentation that simplifies operative workflows and supports accelerated rehabilitation. The payer environment and hospital procurement structures in this region also incentivize clear value propositions and evidence of procedural efficiency.

In Europe, Middle East & Africa, diverse regulatory regimes and heterogeneous healthcare infrastructures require adaptive market-entry approaches. Clinicians in certain markets prioritize long-standing performance records and cost-effective solutions, while others seek innovative materials that address imaging artifacts and long-term integration. Navigating this regional complexity often requires localized clinical engagement strategies and tailored reimbursement narratives.

The Asia-Pacific region presents a combination of high-volume procedural demand and rapidly modernizing clinical infrastructure, creating opportunities for manufacturers that can provide scalable solutions with flexible pricing and training support. Local manufacturing partnerships and regional regulatory agility can accelerate adoption, especially where providers pursue strategies to balance cost containment with access to advanced fixation technologies. Across all regions, understanding the interplay between regulatory pathways, clinician training needs, and supply-chain logistics is essential for sustained commercial success.

Competitive differentiation emerges from clinical evidence, surgeon training ecosystems, and resilient supply-chain and commercialization models that support long-term adoption

Competitive dynamics in the cruciate ligament fixation device space are defined by a mix of established medtech firms and nimble innovators that emphasize differentiated device mechanics, evidence generation, and surgeon training ecosystems. Leading players invest in robust clinical data collection and surgeon education programs to reduce barriers to adoption, while emerging companies often focus on targeted technical breakthroughs-such as novel polymer formulations or simplified instrumentation-to penetrate specific clinical niches.

Partnerships between device companies and centers of excellence accelerate clinical validation and create influential early-adopter networks. Similarly, aftermarket services such as instrumentation sterilization pathways, implant tracking solutions, and training platforms increasingly shape purchasing decisions. Companies that demonstrate end-to-end support-from product reliability to post-market surveillance-command greater credibility with hospital procurement and institutional review committees.

Strategically, firms that balance a clear value proposition with flexible commercial models-ranging from bundled pricing for procedure kits to localized service agreements-tend to navigate channel complexities more effectively. Additionally, supply-chain resilience and the ability to adapt manufacturing footprints in response to tariff or logistics shifts will further differentiate competitors in the coming cycle.

Actionable strategic levers for manufacturers and providers to accelerate adoption through streamlined devices, resilient sourcing, and evidence-driven commercial models

Industry leaders should align product development and commercial strategies with clinician workflows, regulatory expectations, and evolving procurement behaviors to secure durable adoption. Prioritize designs that reduce intraoperative complexity and instrument count, and pair these technical improvements with robust, peer-reviewed clinical evidence and practical training modules that address common adoption friction points. Operationally, invest in modular instrumentation systems that can be customized to different graft types and reconstruction techniques to broaden applicability across surgeon preferences.

Supply-chain diversification and onshore or nearshore manufacturing options will mitigate exposure to tariff-induced cost volatility and logistics disruption. Commercial teams should develop value narratives that quantify procedure-level efficiencies and patient-centric outcomes, and they should collaborate with purchasers to create contracting structures that stabilize pricing while rewarding evidence-based choices. In parallel, cultivate partnerships with high-volume surgical centers to generate real-world data that supports iterative product improvement and strengthens reimbursement conversations.

Finally, implement integrated customer engagement strategies that combine targeted clinical education, digital training tools, and post-market feedback loops. This combination accelerates surgeon proficiency, reinforces product differentiation in competitive tenders, and creates a feedback-rich environment for continuous innovation.

A rigorous mixed-methods approach combining clinical literature, stakeholder interviews, regulatory review, and supply-chain analysis to produce actionable commercial insights

The research methodology underpinning this analysis synthesizes clinical literature review, product performance assessments, regulatory pathway analysis, and stakeholder interviews with surgeons, procurement leaders, and supply-chain managers. Clinical sources were evaluated to extract device performance characteristics, procedural compatibility, and long-term integration considerations, while regulatory reviews focused on device classification, approval timelines, and post-market surveillance expectations across major jurisdictions.

Primary qualitative insights derive from structured interviews with practicing reconstructions surgeons and institutional procurement specialists, offering perspectives on device handling, instrumentation preferences, and purchasing constraints. Supply-chain and tariff impact analysis incorporated trade-policy documentation and industry reports, enabling scenario-based interpretation of sourcing and manufacturing strategies. Competitive positioning insights combine public product specifications, training program characteristics, and reported post-market support initiatives to assess relative differentiation.

Throughout the methodology, emphasis was placed on triangulating findings across multiple independent sources to ensure robustness and to surface actionable implications for product design, clinical engagement, and commercial execution. This approach balances technical rigor with practical relevance for decision-makers.

Converging clinical, material, and commercial priorities require coordinated product, regulatory, and supply-chain strategies to secure sustained clinical adoption

Bringing together clinical trends, material science advances, and commercial imperatives creates a clear imperative for companies to align product innovation with real-world procedural workflows and procurement realities. Devices that reconcile surgeon ergonomics with reproducible fixation mechanics, while addressing material trade-offs between bioabsorbable polymers and metals, will be better positioned to meet diverse clinical demands across hospitals, ambulatory surgical centers, and specialty clinics.

Strategic attention to regional regulatory nuances, tariff-driven sourcing challenges, and the cultivation of evidence and training networks will determine the pace of adoption. Organizations that integrate resilient manufacturing, targeted clinical engagement, and compelling value communication stand to convert technical advantages into sustained clinical utilization. This conclusion underscores the importance of coordinated action across R&D, regulatory, supply-chain, and commercial functions to realize the full potential of fixation innovations.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Cruciate Ligament Fixation Device Market, by Device Type

  • 8.1. Cortical Buttons
  • 8.2. Cross Pins
  • 8.3. Interference Screws
  • 8.4. Staples

9. Cruciate Ligament Fixation Device Market, by Material

  • 9.1. Bioabsorbable Polymer
  • 9.2. Metal

10. Cruciate Ligament Fixation Device Market, by End User

  • 10.1. Ambulatory Surgical Centers
  • 10.2. Hospitals
  • 10.3. Specialty Clinics

11. Cruciate Ligament Fixation Device Market, by Procedure Type

  • 11.1. Anterior Cruciate Ligament Reconstruction
    • 11.1.1. Allograft
    • 11.1.2. Hamstring Tendon Autograft
    • 11.1.3. Patellar Tendon Autograft
  • 11.2. Posterior Cruciate Ligament Reconstruction
    • 11.2.1. Allograft
    • 11.2.2. Hamstring Tendon Autograft
    • 11.2.3. Patellar Tendon Autograft

12. Cruciate Ligament Fixation Device Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Cruciate Ligament Fixation Device Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Cruciate Ligament Fixation Device Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Cruciate Ligament Fixation Device Market

16. China Cruciate Ligament Fixation Device Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Arthrex Inc.
  • 17.6. B. Braun Melsungen AG
  • 17.7. CONMED Corporation
  • 17.8. Corin Group
  • 17.9. Cousin Biotech
  • 17.10. DePuy Synthes
  • 17.11. DJO Global Inc.
  • 17.12. Exactech Inc.
  • 17.13. Integra LifeSciences Holdings Corporation
  • 17.14. Johnson & Johnson Services, Inc.
  • 17.15. Karl Storz SE & Co. KG
  • 17.16. LifeNet Health
  • 17.17. Medacta Group Holding SA
  • 17.18. Medtronic plc
  • 17.19. Miach Orthopaedics
  • 17.20. Olympus Corporation
  • 17.21. Orthocell Ltd
  • 17.22. Orthofix Medical Inc.
  • 17.23. RTI Surgical Holdings, Inc.
  • 17.24. Smith & Nephew plc
  • 17.25. Stryker Corporation
  • 17.26. Tissue Regenix Group plc
  • 17.27. Wright Medical Group N.V.
  • 17.28. Zimmer Biomet Holdings, Inc
  • 17.29. Ossur hf

LIST OF FIGURES

  • FIGURE 1. GLOBAL CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL CRUCIATE LIGAMENT FIXATION DEVICE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL CRUCIATE LIGAMENT FIXATION DEVICE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY DEVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY CORTICAL BUTTONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY CORTICAL BUTTONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY CORTICAL BUTTONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY CROSS PINS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY CROSS PINS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY CROSS PINS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY INTERFERENCE SCREWS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY INTERFERENCE SCREWS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY INTERFERENCE SCREWS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY STAPLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY STAPLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY STAPLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY BIOABSORBABLE POLYMER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY BIOABSORBABLE POLYMER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY BIOABSORBABLE POLYMER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY METAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY METAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY METAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY ANTERIOR CRUCIATE LIGAMENT RECONSTRUCTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY ANTERIOR CRUCIATE LIGAMENT RECONSTRUCTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY ANTERIOR CRUCIATE LIGAMENT RECONSTRUCTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY ANTERIOR CRUCIATE LIGAMENT RECONSTRUCTION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY ALLOGRAFT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY ALLOGRAFT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY ALLOGRAFT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY HAMSTRING TENDON AUTOGRAFT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY HAMSTRING TENDON AUTOGRAFT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY HAMSTRING TENDON AUTOGRAFT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY PATELLAR TENDON AUTOGRAFT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY PATELLAR TENDON AUTOGRAFT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY PATELLAR TENDON AUTOGRAFT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY POSTERIOR CRUCIATE LIGAMENT RECONSTRUCTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY POSTERIOR CRUCIATE LIGAMENT RECONSTRUCTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY POSTERIOR CRUCIATE LIGAMENT RECONSTRUCTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY POSTERIOR CRUCIATE LIGAMENT RECONSTRUCTION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY ALLOGRAFT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY ALLOGRAFT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY ALLOGRAFT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY HAMSTRING TENDON AUTOGRAFT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY HAMSTRING TENDON AUTOGRAFT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY HAMSTRING TENDON AUTOGRAFT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY PATELLAR TENDON AUTOGRAFT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY PATELLAR TENDON AUTOGRAFT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY PATELLAR TENDON AUTOGRAFT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. AMERICAS CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 61. AMERICAS CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 62. AMERICAS CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 63. AMERICAS CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 64. AMERICAS CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 65. AMERICAS CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY ANTERIOR CRUCIATE LIGAMENT RECONSTRUCTION, 2018-2032 (USD MILLION)
  • TABLE 66. AMERICAS CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY POSTERIOR CRUCIATE LIGAMENT RECONSTRUCTION, 2018-2032 (USD MILLION)
  • TABLE 67. NORTH AMERICA CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. NORTH AMERICA CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 69. NORTH AMERICA CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 70. NORTH AMERICA CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 71. NORTH AMERICA CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 72. NORTH AMERICA CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY ANTERIOR CRUCIATE LIGAMENT RECONSTRUCTION, 2018-2032 (USD MILLION)
  • TABLE 73. NORTH AMERICA CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY POSTERIOR CRUCIATE LIGAMENT RECONSTRUCTION, 2018-2032 (USD MILLION)
  • TABLE 74. LATIN AMERICA CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. LATIN AMERICA CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 76. LATIN AMERICA CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 77. LATIN AMERICA CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 78. LATIN AMERICA CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 79. LATIN AMERICA CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY ANTERIOR CRUCIATE LIGAMENT RECONSTRUCTION, 2018-2032 (USD MILLION)
  • TABLE 80. LATIN AMERICA CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY POSTERIOR CRUCIATE LIGAMENT RECONSTRUCTION, 2018-2032 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY ANTERIOR CRUCIATE LIGAMENT RECONSTRUCTION, 2018-2032 (USD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY POSTERIOR CRUCIATE LIGAMENT RECONSTRUCTION, 2018-2032 (USD MILLION)
  • TABLE 88. EUROPE CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. EUROPE CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 90. EUROPE CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY ANTERIOR CRUCIATE LIGAMENT RECONSTRUCTION, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY POSTERIOR CRUCIATE LIGAMENT RECONSTRUCTION, 2018-2032 (USD MILLION)
  • TABLE 95. MIDDLE EAST CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. MIDDLE EAST CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 97. MIDDLE EAST CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 98. MIDDLE EAST CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 99. MIDDLE EAST CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 100. MIDDLE EAST CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY ANTERIOR CRUCIATE LIGAMENT RECONSTRUCTION, 2018-2032 (USD MILLION)
  • TABLE 101. MIDDLE EAST CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY POSTERIOR CRUCIATE LIGAMENT RECONSTRUCTION, 2018-2032 (USD MILLION)
  • TABLE 102. AFRICA CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. AFRICA CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 104. AFRICA CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 105. AFRICA CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 106. AFRICA CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 107. AFRICA CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY ANTERIOR CRUCIATE LIGAMENT RECONSTRUCTION, 2018-2032 (USD MILLION)
  • TABLE 108. AFRICA CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY POSTERIOR CRUCIATE LIGAMENT RECONSTRUCTION, 2018-2032 (USD MILLION)
  • TABLE 109. ASIA-PACIFIC CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. ASIA-PACIFIC CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 111. ASIA-PACIFIC CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 112. ASIA-PACIFIC CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 113. ASIA-PACIFIC CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY ANTERIOR CRUCIATE LIGAMENT RECONSTRUCTION, 2018-2032 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY POSTERIOR CRUCIATE LIGAMENT RECONSTRUCTION, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 117. ASEAN CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. ASEAN CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. ASEAN CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 120. ASEAN CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 121. ASEAN CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 122. ASEAN CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY ANTERIOR CRUCIATE LIGAMENT RECONSTRUCTION, 2018-2032 (USD MILLION)
  • TABLE 123. ASEAN CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY POSTERIOR CRUCIATE LIGAMENT RECONSTRUCTION, 2018-2032 (USD MILLION)
  • TABLE 124. GCC CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 125. GCC CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 126. GCC CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 127. GCC CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 128. GCC CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. GCC CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY ANTERIOR CRUCIATE LIGAMENT RECONSTRUCTION, 2018-2032 (USD MILLION)
  • TABLE 130. GCC CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY POSTERIOR CRUCIATE LIGAMENT RECONSTRUCTION, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPEAN UNION CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPEAN UNION CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPEAN UNION CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPEAN UNION CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPEAN UNION CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPEAN UNION CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY ANTERIOR CRUCIATE LIGAMENT RECONSTRUCTION, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPEAN UNION CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY POSTERIOR CRUCIATE LIGAMENT RECONSTRUCTION, 2018-2032 (USD MILLION)
  • TABLE 138. BRICS CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. BRICS CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 140. BRICS CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 141. BRICS CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 142. BRICS CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 143. BRICS CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY ANTERIOR CRUCIATE LIGAMENT RECONSTRUCTION, 2018-2032 (USD MILLION)
  • TABLE 144. BRICS CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY POSTERIOR CRUCIATE LIGAMENT RECONSTRUCTION, 2018-2032 (USD MILLION)
  • TABLE 145. G7 CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 146. G7 CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 147. G7 CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 148. G7 CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 149. G7 CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 150. G7 CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY ANTERIOR CRUCIATE LIGAMENT RECONSTRUCTION, 2018-2032 (USD MILLION)
  • TABLE 151. G7 CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY POSTERIOR CRUCIATE LIGAMENT RECONSTRUCTION, 2018-2032 (USD MILLION)
  • TABLE 152. NATO CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 153. NATO CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 154. NATO CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 155. NATO CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 156. NATO CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. NATO CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY ANTERIOR CRUCIATE LIGAMENT RECONSTRUCTION, 2018-2032 (USD MILLION)
  • TABLE 158. NATO CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY POSTERIOR CRUCIATE LIGAMENT RECONSTRUCTION, 2018-2032 (USD MILLION)
  • TABLE 159. GLOBAL CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 160. UNITED STATES CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 161. UNITED STATES CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. UNITED STATES CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 163. UNITED STATES CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 164. UNITED STATES CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 165. UNITED STATES CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY ANTERIOR CRUCIATE LIGAMENT RECONSTRUCTION, 2018-2032 (USD MILLION)
  • TABLE 166. UNITED STATES CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY POSTERIOR CRUCIATE LIGAMENT RECONSTRUCTION, 2018-2032 (USD MILLION)
  • TABLE 167. CHINA CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 168. CHINA CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. CHINA CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 170. CHINA CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 171. CHINA CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 172. CHINA CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY ANTERIOR CRUCIATE LIGAMENT RECONSTRUCTION, 2018-2032 (USD MILLION)
  • TABLE 173. CHINA CRUCIATE LIGAMENT FIXATION DEVICE MARKET SIZE, BY POSTERIOR CRUCIATE LIGAMENT RECONSTRUCTION, 2018-2032 (USD MILLION)